ZA978640B - Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. - Google Patents

Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.

Info

Publication number
ZA978640B
ZA978640B ZA9708640A ZA978640A ZA978640B ZA 978640 B ZA978640 B ZA 978640B ZA 9708640 A ZA9708640 A ZA 9708640A ZA 978640 A ZA978640 A ZA 978640A ZA 978640 B ZA978640 B ZA 978640B
Authority
ZA
South Africa
Prior art keywords
saborrheic
pyridones
dermatitis
hydroxy
treatment
Prior art date
Application number
ZA9708640A
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Astrid Markus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA978640B publication Critical patent/ZA978640B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
ZA9708640A 1996-09-27 1997-09-26 Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis. ZA978640B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19639818A DE19639818A1 (de) 1996-09-27 1996-09-27 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis

Publications (1)

Publication Number Publication Date
ZA978640B true ZA978640B (en) 1998-03-27

Family

ID=7807118

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708640A ZA978640B (en) 1996-09-27 1997-09-26 Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.

Country Status (32)

Country Link
EP (1) EP0928183B1 (xx)
JP (2) JP2001500884A (xx)
KR (1) KR100494207B1 (xx)
CN (1) CN1104231C (xx)
AR (1) AR008860A1 (xx)
AT (1) ATE209891T1 (xx)
AU (1) AU716208B2 (xx)
BG (1) BG64365B1 (xx)
BR (1) BR9711575A (xx)
CA (1) CA2267165C (xx)
CY (1) CY2362B1 (xx)
CZ (1) CZ291485B6 (xx)
DE (2) DE19639818A1 (xx)
DK (1) DK0928183T3 (xx)
ES (1) ES2167721T3 (xx)
HK (1) HK1022267A1 (xx)
HU (1) HU226955B1 (xx)
ID (1) ID21874A (xx)
IL (1) IL129141A0 (xx)
MA (1) MA24333A1 (xx)
MY (1) MY125674A (xx)
NO (1) NO312492B1 (xx)
NZ (1) NZ334850A (xx)
OA (1) OA11028A (xx)
PL (1) PL188033B1 (xx)
PT (1) PT928183E (xx)
RS (1) RS49801B (xx)
TR (1) TR199900662T2 (xx)
TW (1) TW519491B (xx)
UA (1) UA57754C2 (xx)
WO (1) WO1998013009A2 (xx)
ZA (1) ZA978640B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639816A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ES2402041T3 (es) 2007-08-31 2013-04-26 Janssen Pharmaceutica, N.V. Combinaciones de imazalil e hidroxipiridonas
CN101877968A (zh) 2007-11-30 2010-11-03 詹森药业有限公司 杀真菌的吡咯化合物和pyrion化合物的组合
CN101932243B (zh) 2008-02-06 2014-04-23 詹森药业有限公司 苯基吡咯和吡啶酮*化合物的组合
EP2587920B1 (en) 2010-07-01 2016-08-10 Janssen Pharmaceutica, N.V. Antimicrobial combinations of pyrion compounds with polyethyleneimines
ES2573116T3 (es) * 2010-12-02 2016-06-06 The University Of Kansas Profármacos de 6-ciclohexil-1-hidroxi-4-metilpiridin-2(1H)-ona y sus derivados
WO2013011996A1 (ja) * 2011-07-19 2013-01-24 リジェンティス株式会社 酵母菌から抽出されたポリリン酸，ポリリン酸の塩又はポリリン酸の溶媒和物を含むポリリン酸組成物及びその製造方法。
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CN104744359B (zh) * 2015-03-06 2017-10-10 上药康丽（常州）药业有限公司 一种环吡酮的精制方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234009C3 (de) * 1972-07-11 1979-01-11 Hoechst Ag, 6000 Frankfurt Kosmetische Zubereitungen
NL8601762A (nl) * 1986-07-07 1988-02-01 Bouke Jan Lange Werkwijze voor de reiniging en conditionering en eventuele medicinale behandeling van het haar en de hoofdhuid, een voor dit doel bruikbare tweefasen shampoo, alsmede een verpakking daarvoor.
CA2143329A1 (en) * 1992-09-08 1994-03-17 Karen K. Kalla Mild, substantially colorless shampoo composition
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
FR2722689B1 (fr) * 1994-07-20 1996-10-04 Fabre Pierre Dermo Cosmetique Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant

Also Published As

Publication number Publication date
AU716208B2 (en) 2000-02-24
AU4774697A (en) 1998-04-17
DE59705697D1 (de) 2002-01-17
BG103260A (en) 2000-01-31
MA24333A1 (fr) 1998-04-01
BR9711575A (pt) 1999-08-24
CN1231595A (zh) 1999-10-13
DE19639818A1 (de) 1998-04-02
NO991460D0 (no) 1999-03-25
CY2362B1 (en) 2004-06-04
JP2006176540A (ja) 2006-07-06
EP0928183A2 (de) 1999-07-14
IL129141A0 (en) 2000-02-17
NO991460L (no) 1999-03-25
EP0928183B1 (de) 2001-12-05
PT928183E (pt) 2002-05-31
WO1998013009A3 (de) 1998-05-14
RS49801B (sr) 2008-06-05
BG64365B1 (bg) 2004-12-30
HUP9903811A3 (en) 2001-11-28
KR20000048613A (ko) 2000-07-25
HK1022267A1 (en) 2000-08-04
ATE209891T1 (de) 2001-12-15
PL188033B1 (pl) 2004-11-30
NZ334850A (en) 2001-02-23
TR199900662T2 (xx) 1999-06-21
AR008860A1 (es) 2000-02-23
MY125674A (en) 2006-08-30
CA2267165C (en) 2003-12-16
KR100494207B1 (ko) 2005-06-13
WO1998013009A2 (de) 1998-04-02
JP2001500884A (ja) 2001-01-23
DK0928183T3 (da) 2002-04-02
CZ291485B6 (cs) 2003-03-12
CN1104231C (zh) 2003-04-02
ID21874A (id) 1999-08-05
CA2267165A1 (en) 1998-04-02
OA11028A (fr) 2003-03-06
TW519491B (en) 2003-02-01
UA57754C2 (uk) 2003-07-15
HUP9903811A1 (hu) 2000-04-28
HU226955B1 (en) 2010-03-29
ES2167721T3 (es) 2002-05-16
NO312492B1 (no) 2002-05-21
CZ107599A3 (cs) 1999-06-16
PL332603A1 (en) 1999-09-27
YU13499A (sh) 2001-09-28

Similar Documents

Publication Publication Date Title
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
ZA97631B (en) Migraine treatment.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
ZA9811507B (en) Combination effective for the treatment of impotence.
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
ZA979731B (en) Treatment of asthma.
EP0612513A3 (en) External skin treatment composition.
ZA978640B (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis.
ZA972515B (en) Acne treatment.
ZA976350B (en) Treatment of liquid.
ZA973843B (en) Treatment of asthma with TNFR-lg.
ZA974570B (en) Device for the production of sponge iron.
GB9615767D0 (en) Novel treatment
ZA977867B (en) Method of treatment.
ZA975637B (en) Method for the treatment of emesis.
ZA973380B (en) Treatment of washwater.
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
GB9726223D0 (en) The treatment of materials
ZA978139B (en) Process for the biological-thermal treatment of waste.
ZA974386B (en) New formulation for treatment of thromboembolism.
ZA976071B (en) Process for the monoacylation of hydroxytaxanes.
PT1011678E (pt) Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina.
ZA9711116B (en) The treatment of materials.
SI0928183T1 (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis